ETF Holdings Breakdown of ZYME

ZYME institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-10-17	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	66,636	USD 1,226,102
2025-10-17	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	63,339	USD 1,165,438
2025-10-17	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	48,658	USD 895,307
2025-10-17	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	48,658	USD 895,307
2025-10-17	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	974	USD 17,922 -1.2%
Total =		228,265	USD 4,200,076

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with ZYME

Citigroup Increases Zymeworks (NYSE:ZYME) Price Target to $22.00

Zymeworks (NYSE:ZYME – Get Free Report) had its price objective hoisted by Citigroup from $19.00 to $22.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s target price points to a potential upside of 68.97% from the stock’s previous close. A […] - 2025-08-13 02:46:43

Zymeworks (NASDAQ:ZYME) Downgraded to Hold Rating by Wall Street Zen

Zymeworks (NASDAQ:ZYME – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday. Zymeworks Price Performance Shares of ZYME stock opened at $12.02 on Friday. The stock has a market cap of $837.55 million, a P/E ratio of […] - 2025-08-11 02:58:46

Cwm LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME)

Cwm LLC increased its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 1,091.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,299 shares of the company’s stock after acquiring an additional 2,106 shares during the quarter. Cwm LLC’s holdings in Zymeworks […] - 2025-08-06 04:27:03

Zymeworks Inc. (NYSE:ZYME) Receives $21.00 Average Price Target from Analysts

Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the […] - 2025-06-24 02:16:45

Ritholtz Wealth Management Decreases Holdings in Zymeworks Inc. (NYSE:ZYME)

Ritholtz Wealth Management lessened its stake in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 18.8% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 60,494 shares of the company’s stock after selling 13,972 shares during the quarter. Ritholtz Wealth Management’s holdings in Zymeworks were worth $720,000 as of its most recent filing […] - 2025-06-19 05:00:55

Assenagon Asset Management S.A. Sells 147,184 Shares of Zymeworks Inc. (NYSE:ZYME)

Assenagon Asset Management S.A. cut its position in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 22.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 495,067 shares of the company’s stock after selling 147,184 shares during the quarter. Assenagon Asset Management S.A. […] - 2025-06-15 05:44:57

Public Employees Retirement System of Ohio Sells 10,400 Shares of Zymeworks Inc. (NYSE:ZYME)

Public Employees Retirement System of Ohio lessened its stake in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 17.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 50,583 shares of the company’s stock after selling 10,400 shares during the period. Public Employees Retirement System of Ohio’s holdings in Zymeworks were worth $741,000 as […] - 2025-06-04 04:56:48

Nuveen Asset Management LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME)

Nuveen Asset Management LLC boosted its stake in Zymeworks Inc. (NYSE:ZYME – Free Report) by 0.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 207,023 shares of the company’s stock after acquiring an additional 886 shares during the period. Nuveen Asset Management LLC’s holdings in Zymeworks were worth $3,031,000 at the end […] - 2025-06-03 04:53:06

Analysts Set Zymeworks Inc. (NYSE:ZYME) Target Price at $21.00

Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have received an average rating of “Moderate Buy” from the ten research firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-05-30 03:06:52

Zymeworks (NYSE:ZYME) Stock Price Up 4.2% After Insider Buying Activity

Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) shot up 4.2% during trading on Tuesday after an insider bought additional shares in the company. The company traded as high as $12.22 and last traded at $12.32. 24,363 shares traded hands during trading, a decline of 96% from the average session volume of 596,591 shares. […] - 2025-05-22 02:32:57

Schonfeld Strategic Advisors LLC Invests $334,000 in Zymeworks Inc. (NYSE:ZYME)

Schonfeld Strategic Advisors LLC purchased a new stake in Zymeworks Inc. (NYSE:ZYME – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,800 shares of the company’s stock, valued at approximately $334,000. A number of other […] - 2025-05-13 04:44:53

Barclays PLC Purchases 66,506 Shares of Zymeworks Inc. (NYSE:ZYME)

Barclays PLC raised its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 43.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 220,890 shares of the company’s stock after purchasing an additional 66,506 shares during the quarter. Barclays PLC’s holdings in Zymeworks […] - 2025-04-29 05:22:53

Legal & General Group Plc Acquires 2,590 Shares of Zymeworks Inc. (NYSE:ZYME)

Legal & General Group Plc increased its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 5.8% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 47,082 shares of the company’s stock after buying an additional 2,590 shares during the quarter. Legal & General Group Plc’s holdings […] - 2025-04-29 04:50:50

Russell Investments Group Ltd. Cuts Stake in Zymeworks Inc. (NYSE:ZYME)

Russell Investments Group Ltd. reduced its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 9.7% during the fourth quarter, Holdings Channel reports. The fund owned 44,945 shares of the company’s stock after selling 4,826 shares during the period. Russell Investments Group Ltd.’s holdings in Zymeworks were worth $658,000 at the end of […] - 2025-04-23 05:20:54

Geode Capital Management LLC Reduces Stock Position in Zymeworks Inc. (NYSE:ZYME)

Geode Capital Management LLC trimmed its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 3.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 689,884 shares of the company’s stock after selling 24,031 shares during the period. Geode Capital Management LLC’s holdings in Zymeworks were worth $10,100,000 as of its […] - 2025-04-23 04:27:03

Renaissance Technologies LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME)

Renaissance Technologies LLC increased its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 54.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 285,700 shares of the company’s stock after buying an additional 101,100 shares during the quarter. Renaissance Technologies […] - 2025-04-22 05:04:52

XTX Topco Ltd Invests $493,000 in Zymeworks Inc. (NYSE:ZYME)

XTX Topco Ltd acquired a new position in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 33,702 shares of the company’s stock, valued at approximately $493,000. Other hedge funds have also made changes to their positions in the […] - 2025-04-21 05:44:47

Federated Hermes Inc. Has $2.66 Million Holdings in Zymeworks Inc. (NYSE:ZYME)

Federated Hermes Inc. grew its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 181,626 shares of the company’s stock after buying an additional 3,367 shares during the period. Federated […] - 2025-04-14 05:15:00

Zymeworks Inc. (NYSE:ZYME) Director Ecor1 Capital, Llc Purchases 196,438 Shares

Zymeworks Inc. (NYSE:ZYME – Get Free Report) Director Ecor1 Capital, Llc purchased 196,438 shares of the firm’s stock in a transaction that occurred on Friday, April 4th. The stock was acquired at an average price of $11.17 per share, with a total value of $2,194,212.46. Following the completion of the purchase, the director now owns […] - 2025-04-09 05:05:20

Zymeworks Inc. (NYSE:ZYME) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating on […] - 2025-04-07 03:06:59

Schroder Investment Management Group Acquires New Shares in Zymeworks Inc. (NYSE:ZYME)

Schroder Investment Management Group bought a new position in Zymeworks Inc. (NYSE:ZYME – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 337,161 shares of the company’s stock, valued at approximately $4,892,000. A number of other hedge funds have also added to […] - 2025-04-06 05:29:07

Zymeworks (NYSE:ZYME) Coverage Initiated by Analysts at Lifesci Capital

Lifesci Capital initiated coverage on shares of Zymeworks (NYSE:ZYME – Free Report) in a research note published on Tuesday,Benzinga reports. The brokerage issued an outperform rating and a $30.00 target price on the stock. A number of other research analysts have also recently commented on ZYME. JPMorgan Chase & Co. upgraded Zymeworks from a “neutral” […] - 2025-03-12 05:08:49

HC Wainwright Issues Positive Forecast for Zymeworks (NYSE:ZYME) Stock Price

Zymeworks (NYSE:ZYME – Free Report) had its target price raised by HC Wainwright from $12.00 to $13.00 in a research note issued to investors on Monday,Benzinga reports. HC Wainwright currently has a neutral rating on the stock. ZYME has been the topic of several other research reports. Wells Fargo & Company raised their price target […] - 2025-03-11 04:02:50

Citigroup Forecasts Strong Price Appreciation for Zymeworks (NYSE:ZYME) Stock

Zymeworks (NYSE:ZYME – Free Report) had its target price raised by Citigroup from $18.00 to $19.00 in a report released on Friday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. A number of other research firms have also weighed in on ZYME. Wells Fargo & Company raised their target price on Zymeworks […] - 2025-03-10 04:44:48

New York State Common Retirement Fund Purchases 4,000 Shares of Zymeworks Inc. (NYSE:ZYME)

New York State Common Retirement Fund lifted its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 42.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,371 shares of the company’s stock after buying an additional 4,000 shares during the period. […] - 2025-03-06 08:19:23

Zymeworks Inc. (NYSE:ZYME) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation […] - 2025-02-21 05:10:59

Back to Listing

Disclaimer